article thumbnail

Customer Relationship Management in Healthcare Industry: Features, Benefits, and Specifics

Viseven

billion by 2025 , with a compound annual growth rate (CAGR) growth of more than 9%. It helps to organize communication processes, keep track of operational activities, and see what works in your management approaches and what requires changes in the current health system. Let’s go. What does CRM stand for in Healthcare?

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

Further compounding the complexity is the highly temperature-sensitive nature of these products, meaning any hiccup faced when processing products outside of their freezer banks can have a serious, knock-on effect. You have very little room for error and need to leverage partners with the expertise and attention to detail to ensure success.

article thumbnail

Message from the Chair an Exciting Year

ISPE

Reintroducing the liaison role of International Board members with individual Chapters and Affiliates has given us direct lines of communication to the mutual benefit of the International Board and the local groups. We defined the path forward for 2023–2025 after a final round of consultations with the Board advisors in July.

article thumbnail

2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives

ISPE

Strategic plan refresh for 2023–2025 involved an adaptation from the existing strategic plan, with the Society taking a “very confident position: Shaping the Future of Pharma and bringing quality medicines to patients worldwide.”. New CoPs are being established, including compounding and quality.

article thumbnail

Today's Biomanufacturing Options - Build, Broker, or Blend?

ISPE

through 2025. You may unsubscribe from these ISPE communications at any time. In fact, the industry is expected to grow at a rate of 28.7% With capacity constraints, it’s no longer a question of if cell and gene therapies will come to market, but how and who will win the race. Leave this field blank Product Development ATMPs Biotech

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Nature Communications 12, no. 3 , 27 Advantages POD increases manufacturing flexibility, speed, and consistency. 3 (2020):e2970.